Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
IS DongSeo Co., Ltd. (010780.KS)
Seoul, KR
Established in 1975 and headquartered in Seoul, South Korea, IS DongSeo Co., Ltd. is a multifaceted enterprise engaged in both construction and the manufacturing of building materials. The company's extensive construction portfolio encompasses a wide array of projects, including residential complexes such as apartments and villas, commercial and mixed-use developments, public infrastructure like roads, bridges, tunnels, and ports, as well as educational institutions, museums, and leisure facilities like golf clubs and resorts. Furthermore, IS DongSeo produces various concrete products, notably PHC piles, concrete segments, and specialized precast concrete components designed for general construction and railway applications.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.37% | +16.70% | +4.39% | -1.33% | +61.59% | +28.02% | +52.46% | -18.07% | -54.02% | -36.13% | +20,862.73% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | -1 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Construction: +2.5%-18.5% Q1'26: +46.1% (vs Q1'25)
-
EPS growth Construction: +11.1%+63.1% ★ Q1'26: +8,169.3% (vs Q1'25)
-
FCF margin FCF growth · Construction: +30.9%+4.0% Q1'26: +31.6% (vs Q1'25)
-
EBIT margin Construction: +8.5%+5.5% Q1'26: +27.5% (vs Q1'25)
-
ROIC Construction: +6.4%+2.7% Q1'26: +14.9% (vs Q1'25)
-
Share dilution Construction: +0.4%-1.3% ★ Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Construction: 0.05×12.64× Q1'26: 2.64× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
945.85B
est: 946.00B (0.0%)
|
1.72T
est: 1.72T (+0.0%)
|
1.83T
est: 1.89T (-2.8%)
|
1.72T
est: 1.69T (+1.6%)
|
964.11B
est: 962.80B (+0.1%)
|
1.20T
est: 1.20T (-0.3%)
|
1.61T
est: 1.55T (+3.9%)
|
2.28T
est: 2.32T (-1.7%)
|
2.03T
est: 1.97T (+2.9%)
|
1.51T
est: 1.56T (-2.8%)
|
1.23T
est: 1.14T (+8.6%)
|
1.39T
1.36T – 1.43T
+22.4% YoY
|
1.55T
1.41T – 1.70T
+11.6% YoY
|
2.03T
1.90T – 2.16T
+30.9% YoY
|
1.64T
1.54T – 1.74T
-19.4% YoY
|
| EBITDA |
177.23B
est: 179.81B (-1.4%)
|
363.80B
est: 327.69B (+11.0%)
|
365.00B
est: 358.42B (+1.8%)
|
392.12B
est: 321.04B (+22.1%)
|
114.49B
est: 183.01B (-37.4%)
|
250.20B
est: 228.94B (+9.3%)
|
348.79B
est: 294.18B (+18.6%)
|
440.87B
est: 440.79B (+0.0%)
|
383.83B
est: 375.02B (+2.3%)
|
215.80B
est: 260.40B (-17.1%)
|
115.44B
est: 189.93B (-39.2%)
|
232.51B
226.52B – 238.50B
+22.4% YoY
|
259.44B
235.02B – 283.85B
+11.6% YoY
|
339.63B
318.28B – 360.98B
+30.9% YoY
|
273.71B
256.50B – 290.91B
-19.4% YoY
|
| EBIT |
145.38B
est: 151.68B (-4.2%)
|
300.97B
est: 276.43B (+8.9%)
|
298.29B
est: 302.35B (-1.3%)
|
373.63B
est: 270.82B (+38.0%)
|
85.72B
est: 154.38B (-44.5%)
|
204.90B
est: 193.13B (+6.1%)
|
300.92B
est: 248.16B (+21.3%)
|
388.75B
est: 371.83B (+4.5%)
|
333.35B
est: 316.35B (+5.4%)
|
165.17B
est: 213.84B (-22.8%)
|
67.99B
est: 155.97B (-56.4%)
|
190.94B
186.02B – 195.86B
+22.4% YoY
|
213.05B
193.00B – 233.10B
+11.6% YoY
|
278.90B
261.37B – 296.43B
+30.9% YoY
|
224.77B
210.64B – 238.90B
-19.4% YoY
|
| Net Income |
101.79B
est: 112.81B (-9.8%)
|
212.34B
est: 216.83B (-2.1%)
|
195.17B
est: 214.62B (-9.1%)
|
245.20B
est: 214.21B (+14.5%)
|
48.36B
est: 67.52B (-28.4%)
|
124.25B
est: 128.70B (-3.5%)
|
104.97B
est: 103.17B (+1.8%)
|
195.68B
est: 203.77B (-4.0%)
|
161.14B
est: 221.09B (-27.1%)
|
-148.66B
est: 22.84B (-750.9%)
|
-53.80B
est: -29.55B (-82.1%)
|
107.72B
84.71B – 130.74B
+464.5% YoY
|
133.76B
117.84B – 149.68B
+24.2% YoY
|
217.56B
199.78B – 235.34B
+62.6% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
94.78B
est: 57.95B (+63.6%)
|
104.14B
est: 105.61B (-1.4%)
|
84.88B
est: 115.52B (-26.5%)
|
87.01B
est: 103.47B (-15.9%)
|
89.65B
est: 58.98B (+52.0%)
|
76.60B
est: 73.78B (+3.8%)
|
74.84B
est: 94.81B (-21.1%)
|
112.39B
est: 142.06B (-20.9%)
|
142.13B
est: 120.87B (+17.6%)
|
116.00B
est: 100.96B (+14.9%)
|
100.53B
est: 73.64B (+36.5%)
|
90.15B
87.83B – 92.47B
+22.4% YoY
|
100.59B
91.12B – 110.05B
+11.6% YoY
|
131.68B
123.40B – 139.95B
+30.9% YoY
|
106.12B
99.45B – 112.79B
-19.4% YoY
|
| EPS |
3,822.00
est: 3,740.00 (+2.2%)
|
7,340.00
est: 7,189.00 (+2.1%)
|
6,355.00
est: 7,115.67 (-10.7%)
|
7,542.00
est: 7,102.00 (+6.2%)
|
1,567.74
est: 2,238.50 (-30.0%)
|
4,070.44
est: 4,267.00 (-4.6%)
|
3,447.87
est: 3,420.40 (+0.8%)
|
6,426.65
est: 6,756.00 (-4.9%)
|
5,338.10
est: 7,330.00 (-27.2%)
|
-4,908.78
est: 767.20 (-739.8%)
|
-1,810.08
est: -992.67 (-82.3%)
|
3,618.75
2,845.53 – 4,391.97
+464.5% YoY
|
4,493.50
3,958.76 – 5,028.24
+24.2% YoY
|
7,308.67
6,711.39 – 7,905.94
+62.6% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-15 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-14 | C | 2/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gab-Jin Kim | MD, Head of Finance Division & Director | — | male |
| Hyuk-Woon Kwon | Chief Executive Officer & Director | — | male |
| Ji-Hye Gwon | Senior MD & Director | — | male |
| Min-Seok Kwon | Chief Executive Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 010780.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
